SIT1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-52153
Key Product Details
Species Reactivity
Human
Applications
Peptide ELISA
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-HLSQWTRGRSRSH corresponding to internal region according to NP_055265.1.
Epitope
C-HLSQWTRGRSRSH
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Description
Please note, this antibody is considered Innovators Grade. Innovators Grade antibodies are generally unvalidated and require additional characterization for most new species/applications. Novus has made these antibodies available through our Innovators Reward program. Complete an online review with image, detailing your positive or negative results. In return, you receive a discount voucher for 100% of the purchase price of the reviewed product. Please contact us at innovators@novusbio.com for more details.
Applications for SIT1 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:2000
Application Notes
WB: Preliminary experiments in human lymph node, spleen, tonsil and thymus lysates gave no specific signal but low background.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: SIT1
Long Name
Signaling Threshold Regulating Transmembrane Adaptor 1
Alternate Names
gp30/40
Entrez Gene IDs
27240 (Human)
Gene Symbol
SIT1
UniProt
Additional SIT1 Products
Product Documents for SIT1 Antibody
Product Specific Notices for SIT1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...